Extended-spectrum beta-lactamase − producing enterobacteriaceae in the intensive care unit: acquisition does not mean cross-transmission

BackgroundIn intensive care unit (ICU), infection and colonization by resistant Gram-negative bacteria increase costs, length of stay and mortality. Extended-spectrum beta-lactamase − producing Enterobacteriaceae (ESBL-E) is a group of pathogens increasingly encountered in ICU setting. Conditions that promote ESBL-E acquisition are not completely understood. The increasing incidence of infections related to ESBL-E and the unsolved issues related to ESBL-E cross-transmission, prompted us to assess the rates of referred and acquired cases of ESBL-E in ICU and to assess patient-to-patient cross-transmission of ESBL-E using a multimodal microbiological analysis.MethodsDuring a 5-month period, all patients admitted to a medical ICU were tested for ESBL-E carriage. A rectal swab was performed at admission and then twice a week until discharge or death. ESBL-E strains were analyzed according to antibiotic susceptibility pattern, rep-PCR (repetitive-element Polymerase chain reaction) chromosomal analysis, and plasmid PCR (Polymerase chain reaction) analysis of ESBL genes. Patient-to-patient transmission was deemed likely when 2 identical strains were found in 2 patients hospitalized simultaneously in the ICU.ResultsAmong the 309 patients assessed for ESBL-E carriage on admission, 25 were found to carry ESBL-E (importation rate: 8 %). During follow-up, acquisition was observed among 19 of them (acquisition rate: 6.5 %). Using the multimodal microbiological approach, we found only one case of likely patient-to-patient ESBL-E transmission.ConclusionsIn unselected ICU patients, we found rather low rates of ESBL-E referred and acquired cases. Only 5 % of acquisitions appeared to be related to patient-to-patient transmission. These data highlight the importance of jointly analyzing phenotypic profile and molecular data to discriminate strains of ESBL-E.

[1]  J. Lucet,et al.  Epidemiology of Multidrug-Resistant Bacteria in Patients With Long Hospital Stays , 2007, Infection Control & Hospital Epidemiology.

[2]  S. Gautam,et al.  High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  A. Shorr Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit* , 2009, Critical care medicine.

[4]  P. Savelkoul,et al.  Extended-Spectrum β-Lactamase Genes of Escherichia coli in Chicken Meat and Humans, the Netherlands , 2011, Emerging infectious diseases.

[5]  J. Vincent,et al.  Intensive Care Unit Outbreak of Extended-Spectrum β-Lactamase–Producing Klebsiella Pneumoniae Controlled by Cohorting Patients and Reinforcing Infection Control Measures , 2008, Infection Control & Hospital Epidemiology.

[6]  R. Hobson,et al.  Multiply-resistant Klebsiella pneumoniae: failure of spread in community-based elderly care facilities. , 1998, The Journal of hospital infection.

[7]  J. Lucet,et al.  Clinical and bacteriologic epidemiology of extended-spectrum β-lactamase-producing strains of Klebsiella pneumoniae in a medical intensive care unit , 1998 .

[8]  F. Tubach,et al.  Clinical predictive values of extended-spectrum beta-lactamase carriage in patients admitted to medical wards , 2011, European Journal of Clinical Microbiology & Infectious Diseases.

[9]  M. Falagas,et al.  Impact of antimicrobial multidrug resistance on inpatient care cost: an evaluation of the evidence , 2013, Expert review of anti-infective therapy.

[10]  A. Harris,et al.  Co-Carriage Rates of Vancomycin-Resistant Enterococcus and Extended-Spectrum Beta-Lactamase-Producing Bacteria Among a Cohort of Intensive Care Unit Patients: Implications for an Active Surveillance Program , 2004, Infection Control & Hospital Epidemiology.

[11]  F. Baquero,et al.  Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[12]  F. Rousset,et al.  Emergence and dissemination of extended-spectrum beta-lactamase-producing Escherichia coli in the community: lessons from the study of a remote and controlled population. , 2010, The Journal of infectious diseases.

[13]  J. Morris,et al.  How important is patient-to-patient transmission in extended-spectrum beta-lactamase Escherichia coli acquisition. , 2007, American journal of infection control.

[14]  G. Arlet,et al.  Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. , 2010, The Journal of antimicrobial chemotherapy.

[15]  Herman Goossens,et al.  Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial , 2014, The Lancet. Infectious diseases.

[16]  L. Guize,et al.  Absence of CTX-M Enzymes but High Prevalence of Clones, Including Clone ST131, among Fecal Escherichia coli Isolates from Healthy Subjects Living in the Area of Paris, France , 2008, Journal of Clinical Microbiology.

[17]  J. Morris,et al.  Multilocus Sequence Typing versus Pulsed-Field Gel Electrophoresis for Characterization of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Isolates , 2005, Journal of Clinical Microbiology.

[18]  D. Church,et al.  Using a Commercial DiversiLab Semiautomated Repetitive Sequence-Based PCR Typing Technique for Identification of Escherichia coli Clone ST131 Producing CTX-M-15 , 2009, Journal of Clinical Microbiology.

[19]  Richard Platt,et al.  Risk of acquiring antibiotic-resistant bacteria from prior room occupants. , 2006, Archives of internal medicine.

[20]  C. Brun-Buisson,et al.  Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program. , 2010, Archives of internal medicine.

[21]  Y. Buisson,et al.  Rectal Carriage of Extended-Spectrum Beta-Lactamase-Producing Gram-Negative Bacilli in Community Settings in Madagascar , 2011, PloS one.

[22]  R. Platt,et al.  Environmental cleaning intervention and risk of acquiring multidrug-resistant organisms from prior room occupants. , 2011, Archives of internal medicine.

[23]  J. Morris,et al.  Patient-to-patient transmission is important in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae acquisition. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  Marc J. M. Bonten,et al.  Duration of colonization with antimicrobial-resistant bacteria after ICU discharge , 2014, Intensive Care Medicine.

[25]  V. Jarlier,et al.  Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. , 1988, Reviews of infectious diseases.

[26]  Jessina C. McGregor,et al.  What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria? , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  V. Roth,et al.  Impact and cost of infection control measures to reduce nosocomial transmission of extended-spectrum beta-lactamase-producing organisms in a non-outbreak setting. , 2007, The Journal of hospital infection.

[28]  Patrick Legrand,et al.  TRANSFERABLE ENZYMATIC RESISTANCE TO THIRD-GENERATION CEPHALOSPORINS DURING NOSOCOMIAL OUTBREAK OF MULTIRESISTANT KLEBSIELLA PNEUMONIAE , 1987, The Lancet.

[29]  F. Baquero,et al.  Dramatic Increase in Prevalence of Fecal Carriage of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae during Nonoutbreak Situations in Spain , 2004, Journal of Clinical Microbiology.

[30]  J. Rickman,et al.  Guilt and dynamics of psychological disorder. , 1948, Lancet.

[31]  M. Gardam,et al.  Is surveillance for multidrug-resistant enterobacteriaceae an effective infection control strategy in the absence of an outbreak? , 2002, The Journal of infectious diseases.

[32]  P. Bradford Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat , 2001, Clinical Microbiology Reviews.

[33]  B S Cooper,et al.  Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature , 2004, BMJ : British Medical Journal.

[34]  F. Baquero,et al.  Assessment of prevalence and changing epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae fecal carriers using a chromogenic medium. , 2010, Diagnostic microbiology and infectious disease.

[35]  N. Safdar,et al.  Adverse effects of isolation in hospitalised patients: a systematic review , 2010, Journal of Hospital Infection.

[36]  A. Kramer,et al.  How long do nosocomial pathogens persist on inanimate surfaces? A systematic review , 2006, BMC infectious diseases.

[37]  J. Lupski,et al.  Microbial DNA Typing by Automated Repetitive-Sequence-Based PCR , 2005, Journal of Clinical Microbiology.

[38]  J. Woo,et al.  Impact of Previous Use of Antibiotics on Development of Resistance to Extended-Spectrum Cephalosporins in Patients with Enterobacter Bacteremia , 2002, European Journal of Clinical Microbiology and Infectious Diseases.

[39]  J. Timsit,et al.  Successful long-term program for controlling methicillin-resistant Staphylococcus aureus in intensive care units , 2005, Intensive Care Medicine.